Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK1 | P23458 | 1/20 | 0.30 |
| ▸ | TYK2 | P29597 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20075973 | 0.84 | MAPK1 (0.36) | ALDH1A1MAPK1TSHRKDM4ELMNA | |
| SCHEMBL973094 | 0.81 | USP2 (0.39) | ALDH1A1CA2TSHRUSP2KDM4E | |
| SCHEMBL20251337 | 0.81 | CES1 (0.32) | ALDH1A1MAPK1 | |
| SCHEMBL14035740 | 0.80 | — | — | |
| SCHEMBL20076249 | 0.79 | ALDH1A1 (0.34) | ALDH1A1MAPK1TSHRCYP2C19 | |
| SCHEMBL10356010 | 0.79 | CA2 (0.32) | CA2 | |
| SCHEMBL2485430 | 0.79 | NLRP3 (0.32) | — | |
| SCHEMBL14839203 | 0.78 | TSHR (0.38) | ALDH1A1CA2MAPK1TSHRUSP2 | |
| SCHEMBL11568327 | 0.78 | — | — | |
| SCHEMBL1170144 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260038886-A1 | SULFONE-BASED ELECTROLYTE AND SECONDARY BATTERY COMPRISING SAME | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-02-05 | — | — | US | claimed |
| CN-109888270-A | Positive electrode, anode pole piece and lithium ion battery for lithium ion battery | 深圳鸿鹏新能源科技有限公司 | 2019-06-14 | — | — | CN | claimed |
| CN-109243860-A | A kind of high voltage withstanding electrolyte and its application in high tension super capacitor | 重庆中科超容科技有限公司 | 2019-01-18 | — | — | CN | claimed |
| CN-109003834-A | A kind of supercapacitor high-voltage electrolyte | 安徽旭峰电容器有限公司 | 2018-12-14 | — | — | CN | claimed |
| US-9997802-B2 | High energy density aluminum battery | UT-BATTELLE, LLC (US) | 2018-06-12 | — | — | US | claimed |
| CN-105070528-A | Electrolyte for supercapacitor | HUNAN CMAX NEW ENERGY TECHNOLOGY CO LTD | 2015-11-18 | — | — | CN | claimed |
| WO-2026099505-A1 | SYSTEM FOR CONTROLLING BATTERY TEMPERATURE | NYOBOLT LIMITED (GB) | 2026-05-15 | — | — | WO | disclosed |
| EP-4634118-B1 | NIOBIUM METAL OXIDE | NYOBOLT LTD (GB) | 2026-04-22 | — | — | EP | disclosed |
| US-20260038886-A1 | SULFONE-BASED ELECTROLYTE AND SECONDARY BATTERY COMPRISING SAME | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-02-05 | — | — | US | disclosed |
| US-20250337004-A1 | COMPOSITE POLYMER CERAMIC ELECTROLYTE | HSBC VENTURES USA INC. | 2025-10-30 | — | — | US | disclosed |
| EP-4634118-A1 | NIOBIUM METAL OXIDE | Nyobolt Limited (GB) | 2025-10-22 | — | — | EP | disclosed |
| EP-4623496-A1 | CHARGING AND DISCHARGING SYSTEM | Nyobolt Limited (GB) | 2025-10-01 | — | — | EP | disclosed |
| US-12407020-B2 | High ionic conductivity polymer electrolyte compositions for alkali and beyond alkali metal batteries | UT-BATTELLE, LLC (US) | 2025-09-02 | — | — | US | disclosed |
| US-20110020712-A1 | ELECTRIC CURRENT-PRODUCING DEVICE HAVING SULFONE-BASED ELECTROLYTE | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-01-27 | — | — | US | disclosed |
| US-7833666-B2 | Electric current-producing device having sulfone-based electrolyte | Arizona Board of Regents for and behalf of Arizona State University (US) | 2010-11-16 | — | — | US | disclosed |
| US-20070298326-A1 | Electric Current-Producing Device Having Sulfone-Based Electrolyte | UNITED STATES DEPARTMENT OF ENERGY | 2007-12-27 | — | — | US | disclosed |
| EP-1842250-A2 | ELECTRIC CURRENT-PRODUCING DEVICE HAVING SULFONE-BASED ELECTROLYTE | Arizona Board of Regents, acting for and on behalf of, Arizona State University (US) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006078866-A2 | ELECTRIC CURRENT-PRODUCING DEVICE HAVING SULFONE-BASED ELECTROLYTE | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2006-07-27 | — | — | WO | disclosed |
| US-6790844-B2 | MUSCLE RELAXANTS; ANTISEROTONINE AGENT | EISAI CO., LTD (JP) | 2004-09-14 | — | — | US | disclosed |
| US-20020013460-A1 | Condensed pyridine compound | EISAI CO., LTD | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013460-A1 | Condensed pyridine compound | MUSK, HTR1A, PAX3 | ALDH1A1 2989/4885CA2 120/4885MAPK1 1599/4885 |
| US-20260038886-A1 | SULFONE-BASED ELECTROLYTE AND SECONDARY BATTERY COMPRISING SAME | CA3, CA2, SLC9A1 | ALDH1A1 3221/4885CA2 2/4885MAPK1 342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.